Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 203,71
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 210,12
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 211,72
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Publicado por Springer US, Springer New York, 2014
ISBN 10: 1493913980 ISBN 13: 9781493913985
Idioma: Inglés
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 217,46
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.
Publicado por Springer US, Springer New York, 2016
ISBN 10: 1493948601 ISBN 13: 9781493948604
Idioma: Inglés
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 217,46
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 218,52
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 234,60
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 234,60
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Publicado por Springer US, Springer New York Sep 2016, 2016
ISBN 10: 1493948601 ISBN 13: 9781493948604
Idioma: Inglés
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 213,99
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 524 pp. Englisch.
Publicado por Springer US, Springer New York Okt 2014, 2014
ISBN 10: 1493913980 ISBN 13: 9781493913985
Idioma: Inglés
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 213,99
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 524 pp. Englisch.
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
EUR 208,64
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
EUR 208,91
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 274,86
Convertir monedaCantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 522.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 311,05
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. reprint edition. 522 pages. 9.25x6.10x1.18 inches. In Stock.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 313,15
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 511 pages. 9.25x6.25x1.25 inches. In Stock.
Librería: moluna, Greven, Alemania
EUR 181,53
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Addresses the challenge to more efficiently select better molecules for drug developmentDiscusses how to expand the chemical space within which a pharmacological benefit can be foundExamines the real value of discovery-oriented pharmac.
Librería: moluna, Greven, Alemania
EUR 181,53
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Addresses the challenge to more efficiently select better molecules for drug developmentDiscusses how to expand the chemical space within which a pharmacological benefit can be foundExamines the real value of discovery-oriented pharmac.
Publicado por Springer New York Sep 2016, 2016
ISBN 10: 1493948601 ISBN 13: 9781493948604
Idioma: Inglés
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 213,99
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state properties and critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings. 524 pp. Englisch.
Publicado por Springer New York Okt 2014, 2014
ISBN 10: 1493913980 ISBN 13: 9781493913985
Idioma: Inglés
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 213,99
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state properties and critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings. 524 pp. Englisch.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 288,90
Convertir monedaCantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 522.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 294,57
Convertir monedaCantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 522.